{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:06:52Z","timestamp":1792094812202,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,22]]},"DOI":"10.7759\/cureus.16561","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T15:25:58Z","timestamp":1626967558000},"source":"Crossref","is-referenced-by-count":5,"title":["Current Modalities for Low Vision Rehabilitation"],"prefix":"10.7759","author":[{"given":"Richa","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"ICD-10. (2019). Accessed. August 2020: https:\/\/icd.who.int\/browse10\/2019\/en#\/H53-H54."},{"key":"ref2","unstructured":"WHO-IAPB vision report 2019. (2019). https.\/\/www.iapb.org\/wp-content\/uploads\/world-vision-report-accessible1.pdf."},{"key":"ref3","article-title":"Visual acuity at home and in eye clinics.","volume":"98","author":"Silver JH","year":"1978","unstructured":"Silver JH, Gould ES, Irvine D, et al.. Visual acuity at home and in eye clinics..  Trans Ophthalmol Soc UK. 1978, 98:262-6.","journal-title":"Trans Ophthalmol Soc UK"},{"key":"ref4","article-title":"Spectacle magnifiers","author":"Rumney NJ","year":"2007","unstructured":"Rumney NJ. Spectacle magnifiers. Low Vision Manual. Jackson AJ, Wolfaohn JS (ed): Butterworth Heinemann Elsevier, Philadelphia; 2007. 223-240."},{"key":"ref5","unstructured":"Low-Vision Aids. (2015). Accessed. May 7, 2021: https:\/\/www.aao.org\/eye-health\/diseases\/low-vision-aids."},{"key":"ref6","article-title":"Telescopes","author":"Wolffsohn JS","year":"2007","unstructured":"Wolffsohn JS. Telescopes. Low Vision Manual. Jackson AJ, Wolfaohn JS (ed):  Butterworth Heinemann Elsevier, Philadelphia; 2007. 241-56."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1117\/1.2940360","article-title":"In-the-spectacle-lens telescopic device","volume":"13","author":"Peli E","year":"2008","unstructured":"Peli E, Vargas-Mart\u00edn F. In-the-spectacle-lens telescopic device. J Biomed Opt. 2008, 13:034027. 10.1117\/1.2940360","journal-title":"J Biomed Opt"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.4.6.8","article-title":"Tunnel vision prismatic field expansion: challenges and requirements","volume":"4","author":"Apfelbaum H","year":"2015","unstructured":"Apfelbaum H, Peli E. Tunnel vision prismatic field expansion: challenges and requirements. Transl Vis Sci Technol. 2015, 4:8. 10.1167\/tvst.4.6.8","journal-title":"Transl Vis Sci Technol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000000820","article-title":"High-power prismatic devices for oblique peripheral prisms","volume":"93","author":"Peli E","year":"2016","unstructured":"Peli E, Bowers AR, Keeney K, Jung JH. High-power prismatic devices for oblique peripheral prisms. Optom Vis Sci. 2016, 93:521-33. 10.1097\/OPX.0000000000000820","journal-title":"Optom Vis Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2017.03.002","article-title":"The use of contact lens telescopic systems in low vision rehabilitation","volume":"40","author":"Vincent SJ","year":"2017","unstructured":"Vincent SJ. The use of contact lens telescopic systems in low vision rehabilitation. Cont Lens Anterior Eye. 2017, 40:131-42. 10.1016\/j.clae.2017.03.002","journal-title":"Cont Lens Anterior Eye"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1364\/OE.21.015980","article-title":"Switchable telescopic contact lens","volume":"21","author":"Tremblay EJ","year":"2013","unstructured":"Tremblay EJ, Stamenov I, Beer RD, Arianpour A, Ford JE. Switchable telescopic contact lens. Opt Express. 2013, 21:15980-6. 10.1364\/OE.21.015980","journal-title":"Opt Express"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1364\/AO.54.007195","article-title":"Wearable telescopic contact lens","volume":"54","author":"Arianpour A","year":"2015","unstructured":"Arianpour A, Schuster GM, Tremblay EJ, et al.. Wearable telescopic contact lens. Appl Opt. 2015, 54:7195-204. 10.1364\/AO.54.007195","journal-title":"Appl Opt"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1364\/AO.54.009597","article-title":"Wink-controlled polarization-switched telescopic contact lenses","volume":"54","author":"Schuster GM","year":"2015","unstructured":"Schuster GM, Arianpour A, Cookson S, et al.. Wink-controlled polarization-switched telescopic contact lenses. Appl Opt. 2015, 54:9597-605. 10.1364\/AO.54.009597","journal-title":"Appl Opt"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.07.010","article-title":"Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results","volume":"113","author":"Hudson HL","year":"2006","unstructured":"Hudson HL, Lane SS, Heier JS, et al.. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results. Ophthalmology. 2006, 113:1987-2001. 10.1016\/j.ophtha.2006.07.010","journal-title":"Ophthalmology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2015.03.021","article-title":"Injectable intraocular telescope: pilot study","volume":"41","author":"Qureshi MA","year":"2015","unstructured":"Qureshi MA, Robbie SJ, Tabernero J, Artal P. Injectable intraocular telescope: pilot study. J Cataract Refract Surg. 2015, 41:2125-35. 10.1016\/j.jcrs.2015.03.021","journal-title":"J Cataract Refract Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-009-2094-y","article-title":"[The IOL-Vip system : principles and clinical application]","volume":"107","author":"Khoramnia R","year":"2010","unstructured":"Khoramnia R, von Mohrenfels CW, Salgado JP, Schweiger B, Engel M, Hadeler J, Lohmann CP. [The IOL-Vip system : principles and clinical application]. Ophthalmologe. 2010, 107:274, 276-80. 10.1007\/s00347-009-2094-y","journal-title":"Ophthalmologe"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2007.08.031","article-title":"Mirror telescopic intraocular lens for age-related macular degeneration: design and preliminary clinical results of the Lipshitz macular implant","volume":"34","author":"Agarwal A","year":"2008","unstructured":"Agarwal A, Lipshitz I, Jacob S, Lamba M, Tiwari R, Kumar DA, Agarwal A. Mirror telescopic intraocular lens for age-related macular degeneration: design and preliminary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008, 34:87-94. 10.1016\/j.jcrs.2007.08.031","journal-title":"J Cataract Refract Surg"},{"key":"ref18","unstructured":"Sulcus-implanted mirror telescopic IOL helpful for AMD, other macular disorders. (2011). Accessed. August 2020: http:\/\/www.healio.com\/ophthalmology\/retina-vitreous\/news\/print\/ocular-surgery news\/%7B69de719e-39b7-4c13-b006-fab76a6...."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2013.10.049","article-title":"Safety and efficacy of an intraocular Fresnel prism intraocular lens in patients with advanced macular disease: initial clinical experience","volume":"40","author":"Potgieter FJ","year":"2014","unstructured":"Potgieter FJ, Claou\u00e9 CM. Safety and efficacy of an intraocular Fresnel prism intraocular lens in patients with advanced macular disease: initial clinical experience. J Cataract Refract Surg. 2014, 40:1085-91. 10.1016\/j.jcrs.2013.10.049","journal-title":"J Cataract Refract Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2015.07.018","article-title":"New add-on intraocular lens for patients with age-related macular degeneration","volume":"41","author":"Scharioth GB","year":"2015","unstructured":"Scharioth GB. New add-on intraocular lens for patients with age-related macular degeneration. J Cataract Refract Surg. 2015, 41:1559-63. 10.1016\/j.jcrs.2015.07.018","journal-title":"J Cataract Refract Surg"},{"key":"ref21","article-title":"OCT imaging in eyes with an implanted telescope","volume":"10","author":"Schlimgen M","year":"2015","unstructured":"Schlimgen M, Fortin MJ, Joondeph BC. OCT imaging in eyes with an implanted telescope. Retina Today. 2015, 10:51-52.","journal-title":"Retina Today"},{"key":"ref22","article-title":"Electronic vision enhancement systems","author":"Wolffsohn JS","year":"2007","unstructured":"Wolffsohn JS. Electronic vision enhancement systems. Low Vision Manual. Jackson AJ, Wolfaohn JS (ed): Butterworth Heinemann Elsevier, Philadelphia; 2007. 257-72."},{"key":"ref23","article-title":"'Smart' cane for the visually impaired: design and controlled field testing of an affordable obstacle detection system","author":"Singh V","year":"2010","unstructured":"Singh V, Paul R, Mehra D, et al.. 'Smart' cane for the visually impaired: design and controlled field testing of an affordable obstacle detection system. Engineering. 2010,","journal-title":"Engineering"},{"key":"ref24","unstructured":"Smart Cane. Accessed. May 7, 2021: http:\/\/smartcane.saksham.org\/overview."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31814b97fd","article-title":"A comparison among Humphrey field analyzer, microperimetry, and Heidelberg retina tomograph in the evaluation of macula in primary open angle glaucoma","volume":"17","author":"Ozt\u00fcrk F","year":"2008","unstructured":"Ozt\u00fcrk F, Yavas GF, K\u00fcsbeci T, Ermis SS. A comparison among Humphrey field analyzer, microperimetry, and Heidelberg retina tomograph in the evaluation of macula in primary open angle glaucoma. J Glaucoma. 2008, 17:118-21. 10.1097\/IJG.0b013e31814b97fd","journal-title":"J Glaucoma"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.159772","article-title":"A comparison between microperimetry and standard achromatic perimetry of the central visual field in eyes with glaucomatous paracentral visual-field defects","volume":"94","author":"Lima VC","year":"2010","unstructured":"Lima VC, Prata TS, De Moraes CG, et al.. A comparison between microperimetry and standard achromatic perimetry of the central visual field in eyes with glaucomatous paracentral visual-field defects. Br J Ophthalmol. 2010, 94:64-7. 10.1136\/bjo.2009.159772","journal-title":"Br J Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10484-007-9038-6","article-title":"Microperimetric biofeedback in AMD patients","volume":"32","author":"Vingolo EM","year":"2007","unstructured":"Vingolo EM, Cavarretta S, Domanico D, Parisi F, Malagola R. Microperimetric biofeedback in AMD patients. Appl Psychophysiol Biofeedback. 2007, 32:185-9. 10.1007\/s10484-007-9038-6","journal-title":"Appl Psychophysiol Biofeedback"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-8415","article-title":"Macular function in macular degenerations: repeatability of microperimetry as a potential outcome measure for ABCA4-associated retinopathy trials","volume":"53","author":"Cideciyan AV","year":"2012","unstructured":"Cideciyan AV, Swider M, Aleman TS, et al.. Macular function in macular degenerations: repeatability of microperimetry as a potential outcome measure for ABCA4-associated retinopathy trials. Invest Ophthalmol Vis Sci. 2012, 53:841-52. 10.1167\/iovs.11-8415","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.4.587","article-title":"Outer retinal degeneration: an electronic retinal prosthesis as a treatment strategy","volume":"122","author":"Loewenstein JI","year":"2004","unstructured":"Loewenstein JI, Montezuma SR, Rizzo JF. Outer retinal degeneration: an electronic retinal prosthesis as a treatment strategy. Arch Ophthalmol. 2004, 122:587-96. 10.1001\/archopht.122.4.587","journal-title":"Arch Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.04.032","article-title":"Long-term results from an epiretinal prosthesis to restore sight to the blind","volume":"122","author":"Ho AC","year":"2015","unstructured":"Ho AC, Humayun MS, Dorn JD, et al.. Long-term results from an epiretinal prosthesis to restore sight to the blind. Ophthalmology. 2015, 122:1547-54. 10.1016\/j.ophtha.2015.04.032","journal-title":"Ophthalmology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2015.09.003","article-title":"The Argus(\u00ae) II retinal prosthesis system","volume":"50","author":"Luo YH","year":"2016","unstructured":"Luo YH, da Cruz L. The Argus(\u00ae) II retinal prosthesis system. Prog Retin Eye Res. 2016, 50:89-107. 10.1016\/j.preteyeres.2015.09.003","journal-title":"Prog Retin Eye Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/cxo.12359","article-title":"An analysis of observer-rated functional vision in patients implanted with the Argus II Retinal Prosthesis System at three years","volume":"99","author":"Geruschat DR","year":"2016","unstructured":"Geruschat DR, Richards TP, Arditi A, et al.. An analysis of observer-rated functional vision in patients implanted with the Argus II Retinal Prosthesis System at three years. Clin Exp Optom. 2016, 99:227-32. 10.1111\/cxo.12359","journal-title":"Clin Exp Optom"},{"key":"ref33","unstructured":"Retinal Implants for RP. An Update on Argus II and Others. (2019). Accessed: May 7, 2021: https:\/\/www.aao.org\/eyenet\/article\/retinal-implants-for-rp."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2013.0077","article-title":"Artificial vision with wirelessly powered subretinal electronic implant alpha-IMS","volume":"280","author":"Stingl K","year":"2013","unstructured":"Stingl K, Bartz-Schmidt KU, Besch D, et al.. Artificial vision with wirelessly powered subretinal electronic implant alpha-IMS. Proc Biol Sci. 2013, 280:20130077. 10.1098\/rspb.2013.0077","journal-title":"Proc Biol Sci"},{"key":"ref35","article-title":"Brainport Vision Technology","volume":"3","author":"Fale A","year":"2016","unstructured":"Fale A, Naik A, Asegaonkar K, Landge A, Atkare G. Brainport Vision Technology. Int Res J Eng Technol. 2016, 3:475-483.","journal-title":"Int Res J Eng Technol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2014.00291","article-title":"Successful tactile based visual sensory substitution use functions independently of visual pathway integrity","volume":"8","author":"Lee VK","year":"2014","unstructured":"Lee VK, Nau AC, Laymon C, Chan KC, Rosario BL, Fisher C. Successful tactile based visual sensory substitution use functions independently of visual pathway integrity. Front Hum Neurosci. 2014, 8:291. 10.3389\/fnhum.2014.00291","journal-title":"Front Hum Neurosci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2015.12.007","article-title":"Cell-based therapy for degenerative retinal disease","volume":"22","author":"Zarbin M","year":"2016","unstructured":"Zarbin M. Cell-based therapy for degenerative retinal disease. Trends Mol Med. 2016, 22:115-34. 10.1016\/j.molmed.2015.12.007","journal-title":"Trends Mol Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-016-0432-y","article-title":"Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study","volume":"7","author":"Oner A","year":"2016","unstructured":"Oner A, Gonen ZB, Sinim N, Cetin M, Ozkul Y. Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study. Stem Cell Res Ther. 2016, 7:178. 10.1186\/s13287-016-0432-y","journal-title":"Stem Cell Res Ther"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10442","article-title":"Cell surgery and growth factors in dry age-related macular degeneration: visual prognosis and morphological study","volume":"7","author":"Limoli PG","year":"2016","unstructured":"Limoli PG, Limoli C, Vingolo EM, Scalinci SZ, Nebbioso M. Cell surgery and growth factors in dry age-related macular degeneration: visual prognosis and morphological study. Oncotarget. 2016, 7:46913-23. 10.18632\/oncotarget.10442","journal-title":"Oncotarget"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181f9c242","article-title":"Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial","volume":"31","author":"Siqueira RC","year":"2011","unstructured":"Siqueira RC, Messias A, Voltarelli JC, Scott IU, Jorge R. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina. 2011, 31:1207-14. 10.1097\/IAE.0b013e3181f9c242","journal-title":"Retina"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-15415","article-title":"Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings","volume":"56","author":"Park SS","year":"2014","unstructured":"Park SS, Bauer G, Abedi M, et al.. Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Invest Ophthalmol Vis Sci. 2014, 56:81-9. 10.1167\/iovs.14-15415","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.158365","article-title":"Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a preliminary report","volume":"10","author":"Weiss JN","year":"2015","unstructured":"Weiss JN, Levy S, Malkin A. Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a preliminary report. Neural Regen Res. 2015, 10:982-8. 10.4103\/1673-5374.158365","journal-title":"Neural Regen Res"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.21037\/sci.2017.11.05","article-title":"Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION)","volume":"4","author":"Weiss JN","year":"2017","unstructured":"Weiss JN, Levy S, Benes SC. Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION). Stem Cell Investig. 2017, 4:94. 10.21037\/sci.2017.11.05","journal-title":"Stem Cell Investig"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.21037\/sci.2018.04.02","article-title":"Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of retinitis pigmentosa","volume":"5","author":"Weiss JN","year":"2018","unstructured":"Weiss JN, Levy S. Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of retinitis pigmentosa. Stem Cell Investig. 2018, 5:18. 10.21037\/sci.2018.04.02","journal-title":"Stem Cell Investig"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2020.09.14","article-title":"Umbilical cord derived mesenchymal stem cell implantation in retinitis pigmentosa: a 6-month follow-up results of a phase 3 trial","volume":"13","author":"Kahraman NS","year":"2020","unstructured":"Kahraman NS, Oner A. Umbilical cord derived mesenchymal stem cell implantation in retinitis pigmentosa: a 6-month follow-up results of a phase 3 trial. Int J Ophthalmol. 2020, 13:1423-9. 10.18240\/ijo.2020.09.14","journal-title":"Int J Ophthalmol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-01870-w","article-title":"Management of retinitis pigmentosa by Wharton's jelly-derived mesenchymal stem cells: prospective analysis of 1-year results","volume":"11","author":"\u00d6zmert E","year":"2020","unstructured":"\u00d6zmert E, Arslan U. Management of retinitis pigmentosa by Wharton's jelly-derived mesenchymal stem cells: prospective analysis of 1-year results. Stem Cell Res Ther. 2020, 11:353. 10.1186\/s13287-020-01870-w","journal-title":"Stem Cell Res Ther"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-018-3953-5","article-title":"Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results","volume":"256","author":"Arslan U","year":"2018","unstructured":"Arslan U, \u00d6zmert E, Demirel S, \u00d6rnek F, \u015eermet F. Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results. Graefes Arch Clin Exp Ophthalmol. 2018, 256:893-908. 10.1007\/s00417-018-3953-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-017-3858-8","article-title":"Longevity of visual improvements following transcorneal electrical stimulation and efficacy of retreatment in three individuals with retinitis pigmentosa","volume":"256","author":"Bittner AK","year":"2018","unstructured":"Bittner AK, Seger K. Longevity of visual improvements following transcorneal electrical stimulation and efficacy of retreatment in three individuals with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2018, 256:299-306. 10.1007\/s00417-017-3858-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2017.10.004","article-title":"Molecular genetics and emerging therapies for retinitis pigmentosa: basic research and clinical perspectives","volume":"63","author":"Dias MF","year":"2018","unstructured":"Dias MF, Joo K, Kemp JA, Fialho SL, da Silva Cunha A Jr, Woo SJ, Kwon YJ. Molecular genetics and emerging therapies for retinitis pigmentosa: basic research and clinical perspectives. Prog Retin Eye Res. 2018, 63:107-31. 10.1016\/j.preteyeres.2017.10.004","journal-title":"Prog Retin Eye Res"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.06.017","article-title":"Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials","volume":"126","author":"Maguire AM","year":"2019","unstructured":"Maguire AM, Russell S, Wellman JA, et al.. Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials. Ophthalmology. 2019, 126:1273-85. 10.1016\/j.ophtha.2019.06.017","journal-title":"Ophthalmology"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/164_2016_91","article-title":"Hereditary retinal dystrophy","volume":"242","author":"Hohman TC","year":"2017","unstructured":"Hohman TC. Hereditary retinal dystrophy. Handb Exp Pharmacol. 2017, 242:337-367. 10.1007\/164_2016_91","journal-title":"Handb Exp Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/64479-current-modalities-for-low-vision-rehabilitation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:06Z","timestamp":1707506886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/64479-current-modalities-for-low-vision-rehabilitation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.16561","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,22]]}}}